반응식
[CH3:1][C:2]1[NH:6][N:5]=[C:4]([C:7]([OH:9])=O)[CH:3]=1.F[P-](F)(F)(F)(F)F.CN(C(ON1C2=NC=CC=C2N=N1)=[N+](C)C)C.[NH:34]1[C:42]2[C:37](=[C:38]([C:43]3[CH:44]=[C:45]([NH2:58])[C:46]4[C:50]([CH:51]=3)=[N:49][N:48](C3CCCCO3)[CH:47]=4)[CH:39]=[CH:40][CH:41]=2)[CH:36]=[CH:35]1>CN(C=O)C.CCN(C(C)C)C(C)C>[NH:34]1[C:42]2[C:37](=[C:38]([C:43]3[CH:51]=[C:50]4[C:46]([CH:47]=[N:48][NH:49]4)=[C:45]([NH:58][C:7]([C:4]4[CH:3]=[C:2]([CH3:1])[NH:6][N:5]=4)=[O:9])[CH:44]=3)[CH:39]=[CH:40][CH:41]=2)[CH:36]=[CH:35]1참가 물질
반응물 3
생성물 1
시약·촉매·용매 2
실험 절차
5-Methyl-1H-pyrazole-3-carboxylic acid (10 mg) in DMF (0.2 ml) was treated with N-[(dimethylamino)(3H-[1,2,3]triazolo[4,5-b]pyridin-3-yloxy)methylidene]-N-methylmethanaminium hexafluorophosphate (27 mg) in DMF (0.2 ml) and DIPEA (0.03 ml). The reaction mixture was shaken for five min prior to treatment with 6-(1H-indol-4-yl)-2-(tetrahydro-2H-pyran-2-yl)-2H-indazol-4-amine (20 mg) in DMF (0.2 ml). The reaction mixture was shaken for five min and left to stand at 22° C. for 18 h. The solvent was removed in vacuo and the product re-dissolved in methanol (1 ml) prior to application on to an SCX SPE cartridge (1 g). The product was eluted after 1 h with 2M ammonia in methanol (2×3 ml), the fractions were combined and concentrated under a stream of nitrogen using blow down apparatus. Purification by mass directed preparative HPLC (Method C) afforded the title compound.
후처리
- stirringThe reaction mixture was shaken for five min
- waitleft
- waitto stand at 22° C. for 18 h
- customThe solvent was removed in vacuo
- dissolutionthe product re-dissolved in methanol (1 ml)
- washThe product was eluted after 1 h with 2M ammonia in methanol (2×3 ml)
- concentrationconcentrated under a stream of nitrogen using blow down apparatus
- customPurification by mass
출처 및 근거
- ORD 기록
- ord-222ac297bb7d4c768557abf89a2cb8ca
- 출처 데이터셋
- uspto-grants-2014_02
- 특허 번호
- US08658635B2
연결된 노트
불러오는 중…